Melissa Cecilia Walsh, MD in Shoreline, WA - Pediatrics

Melissa Cecilia Walsh, MD is a Pediatrics physician based in Shoreline, Washington. Melissa Cecilia Walsh is licensed to practice in Washington (license number ML20008042) and her current practice location is 357 Nw Richmond Beach Rd, Shoreline, Washington. She can be reached at her office (for appointments etc.) via phone at (206) 546-2421.

NPI number for Melissa Cecilia Walsh is 1275644874 and her current mailing address is 357 Nw Richmond Beach Rd, Shoreline, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1275644874.

Contact Information

	Melissa Cecilia Walsh, MD
	357 Nw Richmond Beach Rd, Shoreline, WA 98177-3101
	(206) 546-2421
	Not Available

Physician's Profile

Full Name	Melissa Cecilia Walsh
Gender	Female
Speciality	Pediatrics
Location	357 Nw Richmond Beach Rd, Shoreline, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1275644874
Provider Enumeration Date: 08/31/2006
Last Update Date: 09/15/2011

Medical Identifiers

Medical identifiers for Melissa Cecilia Walsh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275644874	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	ML20008042 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Melissa Cecilia Walsh is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Melissa Cecilia Walsh, MD 357 Nw Richmond Beach Rd, Shoreline, WA 98177-3101 Ph: (206) 546-2421	Melissa Cecilia Walsh, MD 357 Nw Richmond Beach Rd, Shoreline, WA 98177-3101 Ph: (206) 546-2421

News Archive

Study finds reduction in incidence of STEMI after smoking ban implemented in Switzerland

Second-hand smoke increases the risk of coronary artery disease and acute myocardial infarction. For this reason, health policies aimed at reducing tobacco consumption and public smoke exposure are strongly recommended.

Anti-stroke blood thinner shows promise in large clinical trials

In new and extensive clinical trials an experimental blood thinner called rivaroxaban is at least as good at preventing strokes as the drug warfarin – that has been the most widely used agent for the past five decades in people with erratic heartbeats called atrial fibrillations. Researchers said this Monday that this drug also sharply reduces the risk of major bleeding that is seen with warfarin.

Authoritative parenting style associated with frequency of family meals and healthy diet in adolescents

Investigators from the University of Minnesota have found a direct association between parenting style and the frequency of meals eaten together as a family and that an authoritative parenting style was associated with more frequent family meals. Their data further indicated that family meals have a positive influence on adolescents to eat a healthy diet. The results of the study are published in the July issue of the Journal of the American Dietetic Association.

Researchers develop new gene therapy to thwart potential influenza pandemic

Researchers at the Perelman School of Medicine, University of Pennsylvania have developed a new gene therapy to thwart a potential influenza pandemic. Specifically, investigators in the Gene Therapy Program, Department of Pathology and Laboratory Medicine, directed by James M. Wilson, MD, PhD, demonstrated that a single dose of an adeno-associated virus expressing a broadly neutralizing flu antibody into the nasal passages of mice and ferrets gives them complete protection and substantial reductions in flu replication when exposed to lethal strains of H5N1 and H1N1 flu virus.

Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection

Dynavax Technologies Corporation announced today data from two studies that differentiate SD-101 from standard-of-care as well as emerging treatments for chronic HCV infection. The findings of a Phase 1b clinical trial and an in vitro study of SD-101's mechanism of action show that the second-generation TLR9 agonist is well tolerated and safe and induces both IFN-lambda and IFN-alpha at concentrations producing antiviral activity. The data will be presented at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria in April 2010.

Pediatrics Doctors in Shoreline, WA

Ellen Simone Passloff, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1201 N 175th St, Shoreline, WA 98133 Phone: 206-401-3200
Anne H Reese, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 357 Nw Richmond Beach Rd, Richmond Pediatrics, Shoreline, WA 98177 Phone: 206-546-2421 Fax: 206-546-8436
Dr. Marion L Folkemer, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-542-5656 Fax: 206-520-1899
Mr. Donald Robert Milligan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15230 15th Ave Ne, Shoreline, WA 98155 Phone: 206-361-3087 Fax: 206-361-3035
Dr. Susan Mary Hyde, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-542-5656
Mrs. Melissa Nicole Genualdi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 604 Nw Richmond Beach Rd, Shoreline, WA 98177 Phone: 206-533-2900

Melissa Cecilia Walsh, MD - Pediatrics in Shoreline, WA